JPRN-jRCT1080220046未知3 期
Randomized Phase III Study of TS-1 Alone Versus TS-1 Plus CDDP in Advanced Gastric Cancer.
适应症
试验速览
- 阶段
- 3 期
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients with nonresectable or recurrent gastric cancer which is histologically confirmed adenocarcinoma.
排除标准
- 未提供
研究者
相似试验
已完成
3 期
Randomized phase III study of TS-1 alone versus TS-1 plus Lentinan(LNT) in advanced or recurrent gastric cancer (AGC)Advanced or recurrent gastric cancer (AGC)JPRN-UMIN000000574Japanese Foundation for Multidisciplinary Treatment of Cancer300
已完成
2 期
A randomized phase II (/III) study of TXT/TS-1 (DS) combination vs CDDP/5-FU therapy (FUP) in metastatic gastric cancerChemotherapy-naïve metastatic gastric cancerJPRN-C000000104Hiroshima Cancer Therapy Development Organization (HiCTDO)130
未知
2 期
Randomized phase II trial of TS-1 monotherapy versus TS-1 plus gemcitabine therapy in patients with gemcitabine-resistant advanced pancreatic cancerPatients with unresectable advanced pancreatic cancer (Stage IV, TNM Classification) who were primarily resistant to gemcitabine monotherapyJPRN-UMIN000001103Keio University School of Medicine, Department of Medicine, Division of Gastroenterology80
已完成
不适用
Randomized Phase II trial of TS-1 based thrapy vs TS-1 based therapy + LNT for advanced or Recurrent Gastric CancerInoperable or Recurrent Gastric CancerJPRN-UMIN000003156Hiroshima University Hospital90
未知
Unknown
A randomized phase III trial of S-1 versus S-1 plus irinotecan in advanced gastric cancer.Advanced gastric cancerJPRN-jRCT1080220081Yakult Honsha Co., Ltd. ,DAIICHI SANKYO Co.,Ltd.